25(OH)D3 and 1.25(OH)2D3 inhibits TNF-α expression in human monocyte derived macrophages.
<h4>Purpose</h4>We wanted to investigate effects of vitamin D3 (25(OH)D3 and 1.25(OH)2D3) on inflammatory cytokine expression in both activated and non-activated Mφ.<h4>Materials and methods</h4>Mononuclear cells, isolated from healthy donor buffy coats were cultured for a 6-...
Main Authors: | Aisha Rafique, Lars Rejnmark, Lene Heickendorff, Holger Jon Møller |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0215383 |
Similar Items
-
1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) Signaling Capacity and the Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer (NSCLC): Implications for Use of 1,25(OH)2D3 in NSCLC Treatment
by: Pamela A. Hershberger, et al.
Published: (2013-11-01) -
Proceedings: Some long-term effects of 1,25 dihydroxycholecalciferol (1,25(OH)2D3) in man.
by: Henderson, R, et al.
Published: (1974) -
Multiple Sclerosis Patients Show Lower Bioavailable 25(OH)D and 1,25(OH)<sub>2</sub>D, but No Difference in Ratio of 25(OH)D/24,25(OH)<sub>2</sub>D and FGF23 Concentrations
by: Mariska C Vlot, et al.
Published: (2019-11-01) -
The 25(OH)D3, but Not 1,25(OH)2D3 Levels Are Elevated in IBD Patients Regardless of Vitamin D Supplementation and Do Not Associate with Pain Severity or Frequency
by: Anna Zielińska, et al.
Published: (2021-03-01) -
The metabolism of 1,25(OH)2D3 in clinical and experimental kidney disease
by: Mandy E. Turner, et al.
Published: (2022-06-01)